Free Trial
OTCMKTS:AJINY

Ajinomoto 11/6/2025 Earnings Report

Ajinomoto logo
$27.96 0.00 (0.00%)
As of 05/8/2026

Ajinomoto EPS Results

Actual EPS
$0.13
Consensus EPS
$0.21
Beat/Miss
Missed by -$0.09
One Year Ago EPS
N/A

Ajinomoto Revenue Results

Actual Revenue
$2.43 billion
Expected Revenue
$2.66 billion
Beat/Miss
Missed by -$234.32 million
YoY Revenue Growth
N/A

Ajinomoto Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Ajinomoto Earnings Headlines

Nobody Understands Why Trump Is Invading Iran (here’s the answer)
Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.tc pixel
Ajinomoto Co. Inc ADR (AJINY)
See More Ajinomoto Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ajinomoto? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ajinomoto and other key companies, straight to your email.

About Ajinomoto

Ajinomoto (OTCMKTS:AJINY) Co., Inc. is a Tokyo-based multinational food and chemical company best known for commercializing monosodium glutamate (MSG) after Professor Kikunae Ikeda identified the flavor enhancer associated with umami in the early 20th century; the company was founded in 1909. Over more than a century it has grown from its seasoning roots into a diversified group that develops, manufactures and markets food products, seasonings and ingredient solutions for both retail and foodservice customers.

Today Ajinomoto’s activities span prepared and frozen foods, retail seasonings and condiments, and a broad range of amino acid-based products and specialty chemicals. Its amino-acid technologies are applied across food and beverage formulation, animal nutrition, pharmaceutical and medical nutrition products, and industrial uses. The company also participates in health-and-wellness initiatives by producing ingredients used in clinical nutrition, supplements and pharmaceutical applications, while continuing significant operations in processed and frozen consumer foods.

Ajinomoto operates globally with a strong presence in Japan and throughout Asia and expanding operations in the Americas, Europe and other regions through manufacturing, sales subsidiaries and R&D centers. Headquartered in Tokyo, the company maintains an international footprint of production and research facilities and markets products under a variety of brand names. Ajinomoto securities trade internationally, including as an OTC-listed instrument under the symbol AJINY, reflecting its cross-border investor access.

View Ajinomoto Profile